After Orphazyme announced that it would withdraw the application for approval of its drug and delist its ADSs, ORPH stock is falling. More
Articles
Is Monday’s Plunge in Shopify Stock a Warning to Investors?
Growth play SHOP stock has been in a damaging bear market since November, and some insist it’s still not cheap. More
Palantir Stock Continues to Move Higher Based on Analysts’ Revenue and FCF Targets
PLTR stock still has significant upside based on a modest FCF margin of 27% and based on analysts' sales forecasts. More
Three Reasons Why Exxon Stock Will Rise Even if the Price of Oil Falls
Three reasons why Exxon Stock will rise even if the price of oil falls. XOM stock will keep rising even if oil falters, due to cash flow gains from $9 billion in structural cost cuts, expected dividend growth, and a huge new $10 billion buyback program. More
DPRO Stock: Why Is Drone Maker Draganfly Up 90%+ Today?
Draganfly (DPRO) stock is flying higher on Tuesday following news of a major contract for the drone company with Coldchain Delivery Systems. More
Three Reasons Why Nio Stock Could Fly After Its Thursday Earnings Report
Given the global macroeconomic backdrop, China's robust EV demand and NIO's strong execution, NIO stock looks ready to soar. More
